CYP 0.00% 27.0¢ cynata therapeutics limited

Possible Symbiosis

  1. 35 Posts.
    Australian company Admedus has been making headlines recently for its innovative medical material, CardioCel. The tiny, flexible patch, made using part of a cow’s heart, is being used to treat potentially devastating birth defects like congenital heart disease – and it’s taking the international medical community by storm.
    What’s more, we’re proud as punch to say that
    we were integrally involved in its success.
    Our researchers worked with Admedus to assess the suitability of CardioCel for use in stem cell therapy in heart failure patients by comparing it with another commonly-used product. We found that CardioCel was well suited to cardiovascular cell therapy, and that it could have potentially groundbreaking applications in other areas of stem cell delivery too.

    Perhaps a potential symbiosis Cyanata/Admedus
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.